Back
ESC2025 Premium Access

Hemodynamic and symptomatic response in real-world patients with hypertrophic obstructive cardiomyopathy and myosin inhibitor therapy

Session: Management of hypertrophic obstructive cardiomyopathy
Topic: Hypertrophic Cardiomyopathy
Speaker: Mr A. Feidakis (Cologne, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Athanasios Feidakis

University hospital Koln, Cologne (Germany)
1 presentation
0 follower

6 more presentations in this session

Mavacamten in hypertrophic cardiomyopathy: use of accessible functional testing to examine real-world effectiveness

Speaker: Doctor M. Todd (Belfast, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Ablation scar at the his-bundle area predicts persistent complete atrioventricular block requiring pacemaker after alcohol septal ablation for obstructive hypertrophic cardiomyopathy

Speaker: Doctor T. Kawai (Tokyo, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Effect of mavacamten on left ventricular myocardial volume, strain and tissue characteristics in patients with hypertrophic cardiomyopathy

Speaker: Doctor J. Tse (Calgary, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

Real-world symptom and echocardiographic improvement in obstructive HCM patients treated with mavacamten: evidence of favorable disease modification

Speaker: Doctor M. Desai (Cleveland, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Effect of Mavacamten on left ventricular diastolic function and left atrial function in obstructive hypertrophic cardiomyopathy

Speaker: Doctor N. Cohen (Marseille, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Management of hypertrophic obstructive cardiomyopathy

Speakers: Mr A. Feidakis, Doctor M. Todd, Doctor T. Kawai, Doctor J. Tse, Doctor M. Desai...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources